Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple intra-articular icatibant in symptomatic knee osteoarthritis
2006-000763-29Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of icatibant in knee osteoarthritis (OA), sponsored by Sanofi. Primary endpoint: Systemic exposure of icatibant after intra-articular injection. Started Apr 2006; status: completed.
02
Drugs
icatibant
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-000763-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000763-29.